tacrine has been researched along with toloxatone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Annie Rilda, PR; Baek, SC; Grace Thomas Parambi, D; Inasu, ST; Joy, M; Kim, H; Kumar Krishnan, G; Lohidakshan, KK; Mathew, B; Mathew, GE; Nithyamol, P; Pil Lee, J; Randev, RV; Vijayan, V | 1 |
Baek, SC; Cho, ML; Kang, MG; Kim, H; Lee, H; Lee, JP; Oh, SR; Park, CM; Park, D; Park, JE; Ryu, HW | 1 |
Hitge, R; Petzer, A; Petzer, JP | 1 |
5 other study(ies) available for tacrine and toloxatone
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors.
Topics: | 2018 |
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
Topics: Acetylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Coumarins; Enzyme Assays; Humans; Kinetics; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Structure-Activity Relationship | 2019 |
Isatoic anhydrides as novel inhibitors of monoamine oxidase.
Topics: Acetylcholinesterase; Amines; Amino Acids; Anhydrides; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phthalimides; Protein Isoforms; Quinolones; Structure-Activity Relationship | 2022 |